|
Pharmaceutical companies to benefit from new blood cancer drugs
The Pharma Letter … (ibrutinib) will be among the biggest products in blood cancer treatments, and has recently been approved for CLL, while Roche/Biogen Idec’s Gazyva (obinutuzumab) could eventually more than replace its lucrative but mature Rituxan(rituximab … |
Kamada starts POC study of Glassia to treat GVHDPharmaceutical Business ReviewThe POC study is a Phase I/II trial of 24 patients with steroid-resistant GVHD following allogeneic bone-marrow stem cell transplant who will receive six to ten doses of intr…
Sun News Network |
Depression increases risk of heart failure: Study
Sun News Network Moderate to severe depression increases the risk of heart failure by 40%, according to a Norwegian study involving nearly 63,000 people. “The more depressed you feel, the more you are at risk,” lead author Lise Tuset Gustad said in a news release. |
|
Maarten van der Weijden: A look inside the mind of an Olympic Champion
Olympic Suddenly engaged in a battle for his life rather than for medals, he underwent a successful stem cell transplant, and jubilantly returned to the water two years later. The Alkmaar-born swimmer’s sense of ambition was not in the slightest dampened … |
Medical DailyDepression Can Increase Your Chances Of Heart Failure by 41%: StudyMedical DailyA recent study has found a direct association between depression and heart failure. According to the data, individuals suffering from depression increase their…
Counsel & Heal |
Can a transplant drug help eliminate lingering HIV infections?
Los Angeles Times In a paper published this week in the American Journal of Transplantation, authors found that when a small group of transplant patients received the drug sirolimus, they experienced a two- to threefold drop in HIV levels, whereas patients who received … Sirolimus Reduces Post-Transplant HIV LevelsRenal and Urology News Could transplant drugs replace antiretrovirals in HIV treatment?Medical News Today Transplant Drugs May Help Wipe Out Persistent HIV InfectionsRedOrbit |
Dallas Morning News |
Blue nail polish sold to benefit Coppell-based organ donor group
Dallas Morning News The color is based on Taylor’s eyes. Learn more and purchase at taylorsgift.org. April is National Donate Life Month. Taylor’s Gift hopes to raise $100,000 help provide financial help to families touched by organ donation. Last year’s campaign raised … |
Primary Endpoint Met in Eye Disorder StudyMonthly Prescribing ReferenceRapamune is approved for organ rejection prophylaxis in renal transplant patients in combination with cyclosporine and corticosteroids. CYPHER (Sirolimus-eluting Coronary Stent) is …
Research and Markets: European Therapeutic Drug Monitoring (TDM) Market …Business Wire (press release)… Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, …
Method for delivering HIV-fighting antibodies proves even more promisingdomain-BIn 2011, biologists at the California Institute of Technology (Caltech) demonstrated a highly effective method for delivering HIV-fighting antibodies to mice-a treatment th…